| HRA005868
(Controlled Access)
|
In this study, we intend to conduct whole-genome and transcriptome analysis of tumor tissues and blood samples from prostate cancer patients. Using bioinformatics methods, we aim to identify personalized, patient-specific neoantigens in order to better understand the immunological characteristics of the tumors. Furthermore, we will assess whether the selected neoantigens possess sufficient immunogenicity to elicit a strong immune response, thus contributing to the induction of a lasting anti-cancer immune response. This research is aimed at screening and identifying personalized neoantigens for prostate cancer, which will help in designing cancer vaccines and immunotherapy strategies for patients. It will also provide insights into the potential of immunotherapy in prostate cancer and offer crucial information for the development of future immunotherapeutic strategies. |
